Immatics (IMTX) Interest Coverage Ratio (2019 - 2025)
Immatics recorded quarterly Interest Coverage Ratio of 75.5 in Q4 2025, down 60.06% quarter-over-quarter from 189.04 in Q3 2025, and up 33518.36% year-over-year from N/an in Q4 2024.
Immatics' Interest Coverage Ratio history runs 7 years deep, the most recent figure standing at 75.5 for Q4 2025.
- In Q4 2025, Interest Coverage Ratio rose 33518.36% year-over-year to 75.5; the TTM figure through Dec 2025 stood at 5.07 (up 28.69% YoY), while the FY2025 annual figure was 4.96, down 83.02% from the prior year.
- Interest Coverage Ratio came in at 75.5 for Q4 2025 at Immatics, down from 189.04 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 189.04 in Q3 2025 to a low of 340.54 in Q1 2021.
- A 5-year average of 16.95 and a median of 16.2 in 2023 frame the typical range for Interest Coverage Ratio.
- Across the five-year window, Interest Coverage Ratio plunged 187.54% in 2021 and soared 463104.62% in 2025, its largest moves.
- Immatics' Interest Coverage Ratio stood at 49.26 in 2021, then slumped by 100.01% to 0.01 in 2022, then jumped by 134786.25% to 9.58 in 2023, then slumped by 97.65% to 0.22 in 2024, then jumped by 33518.36% to 75.5 in 2025.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 75.5, 189.04, and 2.33 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -129.79 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 3.58 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -258.33 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 11.50 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 49.84 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 3.88 |
| 10 | Immatics | 1.80 Bn | 1.80 Bn | - | 75.50 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 75.50 |
| Sep 30, 2025 | 189.04 |
| Jun 30, 2025 | 2.33 |
| Mar 31, 2025 | 2.65 |
| Dec 31, 2024 | 0.22 |
| Sep 30, 2024 | -0.04 |
| Jun 30, 2024 | 87.10 |
| Mar 31, 2024 | 19.90 |
| Dec 31, 2023 | 9.58 |
| Sep 30, 2023 | 21.12 |
| Jun 30, 2023 | 12.51 |
| Mar 31, 2023 | 7.53 |
| Dec 31, 2022 | -0.01 |
| Sep 30, 2022 | 51.47 |
| Jun 30, 2022 | 40.93 |
| Mar 31, 2022 | -61.32 |
| Dec 31, 2021 | 49.26 |
| Sep 30, 2021 | 134.51 |
| Jun 30, 2021 | 37.20 |
| Mar 31, 2021 | -340.54 |
| Dec 31, 2020 | 1.95 |
| Sep 30, 2020 | 2.80 |
| Jun 30, 2020 | 9.06 |
| Mar 31, 2020 | 389.00 |
| Dec 31, 2019 | -37.45 |
| Sep 30, 2019 | 127.15 |
| Jun 30, 2019 | 13.66 |